Arch Biopartners, U of Calgary Extend Agreement

Corporate Breaking News

Home : Arch Biopartners, U of Calgary Extend Agreement

Jul 07 2011	Arch Biopartners, U of Calgary Extend Agreement
TORONTO, ONTARIO--(Marketwire - July 6, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) today announced that the University of Calgary has extended the overhead agreement with its subsidiary Arch Biotech Inc. ("AB") and has granted a similar overhead agreement to its subsidiary Arch Cancer Therapeutics Ltd ("ACT").


Source:http://www.marketwire.com/mw/release.do?id=1535366&sourceType=3

Related News
» Universal Technical Institute Schedules Fiscal 2011 Third Quarter Earnings Release and Conference Call » Wind Works Power Corp: Debt Financing of 7.188 Million Euro Closed for Wind Park Burg I in Germany